We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Ablatus Therapeutics is a MedTech company developing a one-of-a-kind tissue ablation platform known as Bimodal Electric Tissue Ablation (BETA). This technology has been designed to overcome the limitations of existing products by offering ablation solutions in oncology (tumours) as well as non-oncology targets. With the proceeds, the company will finish the final elements of engineering of the generator and probe. It will also deliver formal safety test data that is a prerequisite for subsequent clinical trials.
days to go: Expired investment: Withheld
Antev Limited (Antev) is a clinical-stage biopharmaceutical firm which focuses on the evolution of a drug used for prostate cancer, Teverelix TFA. The company is working on growing its copyright protection and is currently developing phase IIb clinical plans for prostate cancer. Antev is a pre-revenue company that aims at increasing its shareholder value by progressing the development of teverelix TFA towards registration whose approval is anticipated from 2023 onwards. The proceeds will be used for production, IP development, working capital and to develop a phase IIb repeat dosing clinical trial in prostate cancer.
days to go: Expired investment: Withheld
Arca have introduced new tools for property risk management and created a marketplace to trade portfolio risks to match buyers and sellers of financial products connected to the performance of real estate. They are opening up the concept of short term property market risk management for property portfolio managers.  
days to go: Expired investment: £575,000
Billon have created a technology that enables zero cost global payments by the use of a simple mobile app. Billon's mobile app allows you to instantly pay for the rest of an article from the Guardian or even donate to your favourite Youtubers with a few clicks of a button. 
days to go: Expired investment: £1,406,667
Caldera is a heat battery company that seeks to institutionalise zero-carbon energy solutions for the masses. It asserts that its 'Zero Carbon Boiler' is a direct replacement to an oil or gas boiler by providing low-cost renewable electricity as heat for later use on demand by the homeowner. The company asserts that the boiler consists of two elements. The first is Caldera's proprietary 'Warmstone Heat Battery' that can be charged by low-cost electricity from the grid, store that electricity for 24 hours and provide it on demand. The second is a 'Heat Interface Unit' (HIU) that replaces the existing boiler. Caldera believes that low electricity prices always tend to occur when the source of electricity is also low carbon. It will use the investment to grow its business across different verticals.
days to go: Expired investment: £615,000
CareGREEN is an innovation company that has created a unique air pollution capture and storage technology with the aim to reduce harmful pollution in the atmosphere. Their latest product is the Environmental Air Purification Intervention & Control System (EAPICS). The technology has been accredited as a significant solution in reducing COx worldwide. A World Health Organisation (2016) report established that more than 80% of people living in urban areas face the greatest environmental risk to their health today due to air pollution. CareGREEN believes its specialised filtration systems will contribute to a considerable fall in health issues linked to poor air quality. It is also diversifying its reach in other renewable energy sectors such as solar and wind. The company will utilise the investment to scale its business.
days to go: Expired investment: Withheld
Co-Space is a forward-thinking flexible office operator with a focus on affluent towns and cities outside Central London. Established in 2018, Co-Space has thrived even during the pandemic, boasting two successful sites in Reading (95% occupied) and Stevenage (93% occupied). Our approach involves transforming underutilized spaces into highly sought-after flexible offices, incorporating exceptional interior design and dedicated service. With a revenue run rate of £1.5 million and over 90% of it being contracted and recurring, Co-Space is a promising contender, bridging the gap between exceptional London design and regional competition.
days to go: Expired investment: £50,000
Cyance is an award-winning marketing technology pioneer. Nexus is a software platform designed by the company to track the buying behaviour through billions of computers belonging to millions of businesses across the globe. This platform can track the consumed content and identifies customer interests and needs. The company's customers typically generate x3 more leads and x4 more sales. With the proceeds, Cyance will increase its marketing sales and improve product development to fund the general working capital.
days to go: Expired investment: Withheld
Intelligent Health aim to get the whole community active by providing games and incentives such as ''beat the street''. By providing schools and communities with friendly competition to walk and cycle more by tapping their cards on ''beat boxes'', and with prizes and league tables on offer, Intelligent health are bringing communities together. 
days to go: Expired investment: £700,000
ITIG have developed software to aid in understanding the investment process, as well as reducing the associated costs of investing. Using their licensed methodologies, retail and institutional investors will see return funds which are more predictable when investing in Exchange Traded Funds (ETFs), resulting in highly diverse and low-cost investment portfolio.
days to go: Expired investment: £67,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph